Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a ...
For further details and a discussion of these and other risks and uncertainties, please see Biotel’s public filings with the Securities and Exchange Commission, including Biotel’s latest periodic ...
It's been a tough couple of months for wireless arrhythmia monitoring company CardioNet: The company has terminated its plans to acquire Minnesota-based Biotel, which has its own cardiac arrhythmia ...
When it comes to diagnosing and treating arrhythmias, time is of the essence. Delays can cause anxiety for patients, or, on the extreme end, death. Twelve-year-old device firm CardioNet Inc.
US-based medical technology company CardioNet has pulled out of its previously announced acquisition of cardiac monitoring specialist Biotel, accusing the latter of failing to comply with the terms of ...
Pennsylvania-based CardioNet said Monday that it is buying Biotel, an Eagan-based medical technology company, for $11 million. But just last year, CardioNet made a similar agreement then backed out, ...
As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone Almost eight times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results